AGP
LLY icon

Aspire Growth Partners’s Eli Lilly LLY Stock Holding History

Aspire Growth Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$985K Buy
1,071
+2
+0.2% +$2.03K 0.68% 34
2025
Q4 		$1.15M Sell
1,069
-98
-8% -$93.7K 0.8% 23
2025
Q3 		$891K Buy
1,167
+9
+0.8% +$6.7K 0.65% 34
2025
Q2 		$903K Sell
1,158
-54
-4% -$42K 0.74% 32
2025
Q1 		$941K Buy
1,212
+58
+5% +$48.3K 0.84% 32
2024
Q4 		$891K Buy
+1,154
New +$956K 0.87% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aspire Growth Partners's LLY Position: Q1 2026 in Review

Aspire Growth Partners increased its Eli Lilly (LLY) stake by 0.19% in Q1 2026, buying an estimated $2.03K and bringing the position to 1,071 shares worth $985K. The position accounts for 0.68% of the portfolio, ranked #34.

Aspire Growth Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.15M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Aspire Growth Partners held 1,071 shares of Eli Lilly worth $985K as of Q1 2026.
  • Aspire Growth Partners bought 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
  • Eli Lilly made up 0.68% of Aspire Growth Partners's portfolio in Q1 2026, its #34 holding.
  • Aspire Growth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Aspire Growth Partners's Eli Lilly position peaked at $1.15M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Aspire Growth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.